U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214922) titled 'Relative Bioavailability of Evobrutinib Tablet Batches' on Oct. 08.
Brief Summary: The main purpose of the study is to compare the Pharmacokinetics (PK), safety and tolerability of different manufacturing batches of M2951 tablet formulation relative to a reference batch under fasted conditions in healthy participants.
Study Start Date: Jan. 18, 2023
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Treatment A
Participants will receive single dose of Treatment A in treatment period 1, 2, 3 or 4 under fasted conditions.
DRUG: Treatment B
Participants will receive single dose of Treatment B in treatment period...